Dr. George Joseph Vellanikaran, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 20 Francis Way, Suite 101, Sharpsburg, GA 30277 Phone: 770-253-0611 Fax: 770-502-0521 |
Parul Dutta, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 125 Platinum Rdg, Sharpsburg, GA 30277 Phone: 917-808-3968 |
Lee Larowe, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 144 Northwoods Rd, Sharpsburg, GA 30277 Phone: 678-876-5751 |
Jerma Caren Adams, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 105 Fischer Marketplace Ln Ste 100, Sharpsburg, GA 30277 Phone: 678-633-3260 |
News Archive
In most cases, tumors of the thymus gland are removed by surgical resection. However, they recur after a few years in up to one third of patients. A research team headed up by thoracic surgeon Bernhard Moser of the Thoracic Surgery Department at MedUni Vienna has successfully demonstrated that these tumors form heat-shock proteins. The lower the concentration of these proteins, the more quickly tumors recur. The study has been published in the leading journal Scientific Reports.
The discovery of these biomarkers could lead to a definitive test for IC and have the potential to lead to new therapies. Results of two studies are being presented today at the annual meeting of the American Urological Association (AUA) in San Antonio, and are published in abstracts 69 and 80 of the AUA proceedings.
Scientists at the Institute of Molecular Biology (IMB) in Mainz have identified a protein essential for initiating the development of male sex organs. Loss of the gene Gadd45g results in complete sex reversal of male mice, making them appear female.
Although scientists and stock markets have celebrated the approval for emergency use of remdesivir to treat COVID-19, a cure for the disease that has killed nearly 260,000 people remains a long way off — and might never arrive.
Cancer Research UK-funded scientists have determined that a magnetic resonance imaging (MRI) technique, which measures the movement of water molecules within the tumour, may be the best way to monitor how women with late-stage ovarian cancer are responding to treatment. The study is published in the journal Radiology today.
› Verified 3 days ago